Global Drug Delivery Systems Market Assessment, By Product [Prefilled Syringes, Autoinjectors, Infusion Pumps, Metered Dose Inhalers, Nebulizers, Nasal Sprays, Eyedroppers, Intrauterine Devices], By Route of Administration [Pulmonary Drug Delivery, Transmucosal Drug Delivery, Nasal Drug Delivery, Oral Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, Injectable Drug Delivery, Ocular Drug Delivery], By Application [Autoimmune Diseases, Cardiovascular Diseases, Cancer, Infectious Diseases, Respiratory Diseases, Central Nervous System Diseases, Diabetes, Others], By End-user [Hospitals, Ambulatory Surgical Centers, Home Care Settings, Diagnostic Centers, Others], By Region, Opportunities and Forecast, 2017-2031F
Global drug delivery systems market is being propelled by the escalation of chronic diseases, the surge in demand for self-administration devices, advancements in technology, the prominence of biologics and large molecule drugs, increased investment, supportive regulatory frameworks, and the advent of personalized medicine.
Home>Industry Reports>Global Drug Delivery Systems Market Assessment, Opportunities and Forecast, 2017-2031F
Global drug delivery systems market is projected to witness a CAGR of 9.14% during the forecast period 2024-2031, growing from USD 151.6 billion in 2023 to USD 305.19 billion in 2031. The dynamics shaping the global drug delivery systems market encompass a spectrum of elements, such as the escalation of chronic diseases, the surge in demand for self-administration devices, advancements in technology, the growth of the geriatric population, the prominence of biologics and large molecule drugs, increased investment, collaborative partnerships, the burgeoning market in emerging economies, supportive regulatory frameworks, and the advent of personalized medicine.
The global drug delivery systems market is in a phase of significant transformation, driven by a diverse range of influential factors. The escalating incidence of chronic diseases, such as cancer, diabetes, and cardiovascular conditions, serve as a pivotal force, stimulating the need for more efficient and targeted drug delivery methods. Concurrently, there's a notable surge in patient preference for self-administration tools, aiming for convenience and self-management in their therapies. Furthermore, the continual advancement of technology assumes a crucial role in enhancing drug delivery systems. Additionally, the increasing elderly population, with its unique healthcare requirements, underscores the demand for tailor-made delivery systems designed specifically for older individuals in the global drug delivery systems market.
The global drug delivery systems market configuration is further influenced by the prominence of biologics and large molecule drugs, necessitating sophisticated delivery platforms to ensure efficient administration. Collaborative alliances between pharmaceutical firms and research institutions drive innovation, accelerating the creation and commercialization of pioneering delivery systems. Concurrently, the burgeoning healthcare markets in developing economies present unexplored avenues for expansion, buoyed by supportive regulatory frameworks that facilitate research and development ventures. The emergence of personalized medicine, focused on customized therapies tailored to individual patient needs, signifies a substantial shift, fueling the quest for personalized drug delivery solutions on a global scale and boosting the global drug delivery systems market.
Surge in Demand for Self-Administration Devices
The rising demand for self-administration devices is a key catalyst driving the global drug delivery systems market expansion. Patients increasingly desire independence and ease in handling their treatments, resulting in a noticeable uptick in the uptake of such devices. These self-administration solutions, including injectable pens, wearable technologies, and other user-friendly tools, grant patients’ greater autonomy in managing their therapies, simplifying the treatment process. This upsurge mirrors a change in patient preferences and underscores a fundamental shift in healthcare delivery, highlighting the significance of personalized and convenient treatment choices. As a result, the market for drug delivery systems is experiencing substantial growth, fueled by the escalating preference for self-administration devices among healthcare consumers worldwide.
Increased Investments
Numerous corporations are reinforcing their financial commitments in the global drug delivery systems sector, demonstrated through the creation of fresh production facilities. This strategic endeavor entails the construction of cutting-edge sites geared towards manufacturing sophisticated drug delivery systems. By expanding their manufacturing prowess, firms endeavor to satisfy increasing market needs, pioneer inventive delivery approaches, and streamline production efficiency. These investments reflect a dedication to augment research, development, and production capabilities, enabling the companies to seize the burgeoning prospects within the ever-changing pharmaceutical arena.
For instance, in March 2023, Genixus, a firm dedicated to producing and creating drug delivery systems, declared the completion of a new manufacturing facility in Concord, N.C. The site is equipped with automated manufacturing and state-of-the-art technology specifically designed to bolster the KinetiX syringe platform and broaden its product range. This increase in manufacturing capability is a direct response to the market's call for ready-to-administer (RTA) syringes.
Government Initiatives
Governments globally are proactively executing various programs to nurture the expansion of the worldwide drug delivery systems market. These initiatives involve diverse approaches like incentivizing research and development, simplifying regulatory processes to hasten approvals, and offering financial aid or grants to spur innovation. Furthermore, certain governments are cultivating partnerships between educational institutions, industries, and research centers, easing the transfer of technology, and encouraging investments in sophisticated drug delivery technologies. These extensive actions reflect a unified endeavor to propel progress in drug delivery systems, aiming for enhanced treatments, improved patient results, and meeting evolving healthcare demands globally.
For example, in February 2021, the Union Cabinet of India approved the Production Linked Incentive (PLI) initiative tailored for the pharmaceutical sector. The scheme aims to elevate India's manufacturing capacities by augmenting investments and production within the sector, fostering the expansion of product diversity towards high-value pharmaceutical goods. Additionally, the scheme seeks to cultivate globally competitive entities in India, empowering them to expand in scope and magnitude by integrating advanced technology, thus enabling their integration into global value chains.
Growing demand for Autoinjectors
There's a notable increase in the global drug delivery systems market's interest in autoinjectors. These tools facilitate patient-friendly, self-administered medication, especially advantageous for individuals needing regular injections. The escalating incidence of chronic illnesses and the preference for home-based healthcare solutions play a role in driving this escalated need. Autoinjectors ensure accuracy in dosing, ease of use, and a decrease in medical mistakes, promoting patient adherence to treatments. Additionally, technological advancements, improvements in design, and the widening application of injectable medications in various therapeutic areas contribute to the growing acceptance of autoinjectors. Consequently, they emerge as a pivotal driver in the expansion of the drug delivery systems market.
For instance, in September 2023, Ypsomed, a Swiss medical technology firm, disclosed a prolonged supply agreement with Novo Nordisk for autoinjectors. This partnership highlights the advantageous impact of the Danish pharmaceutical company's weight-loss drug business on firms specializing in pharmaceutical services. Ypsomed plans to increase its production capacities in the upcoming years, with Novo Nordisk playing a substantial role by investing in the added production infrastructure.
Drug Delivery Systems for Diabetes
The escalating demand for drug delivery systems tailored for diabetes treatment significantly drives growth within the global drug delivery systems market. Diabetes, a prevalent chronic condition, requires consistent and precise medication administration. This heightened demand stems from the need for effective delivery mechanisms ensuring optimized drug dosing, improved patient compliance, and reduced treatment-associated complications. With advancements in diabetes management and the expansion of therapeutic options, the market experiences an upsurge in innovative drug delivery systems catering specifically to diabetic patients, thereby contributing substantially to the market's expansion and evolution.
For example, Terumo India, the Indian division of Terumo Corporation, a prominent global player in medical technology, unveiled an insulin syringe on November 14, 2023. This sterile delivery device caters to patients needing frequent insulin injections, elevating standards for patient comfort and adherence to therapy.
Future Market Scenario (2024-2031F)
The future prospects of the global drug delivery systems market display a high level of promise. Several factors contribute to this positive outlook, notably ongoing technological advancements that consistently refine drug delivery techniques. These innovations result in more accurate, targeted, and efficient medication administration, elevating treatment effectiveness, while reducing potential side effects. Moreover, the escalating prevalence of chronic diseases like cancer, diabetes, and cardiovascular ailments worldwide drives the demand for advanced drug delivery systems. This need is amplified by an increasingly aging population requiring specialized treatment modalities. Additionally, the industry's response to global health crises, such as the COVID-19 pandemic, has expedited research and development, yielding rapid progress in vaccine delivery methods and therapeutics. The continual expansion of healthcare infrastructure in emerging economies and the emphasis on personalized medicine further propels the ongoing evolution and potential expansion of the global drug delivery systems market.
Report Scope
“Drug Delivery Systems Market Assessment, Opportunities, and Forecast, 2017-2031F”, is a comprehensive report by Markets and data, providing in-depth analysis and qualitative and quantitative assessment of the current state of the global drug delivery systems market, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, future market scenario, opportunities, and forecast between 2024 and 2031. Additionally, the report profiles the leading players in the industry mentioning their respective market share, business model, competitive intelligence, etc.
In this report, the global drug delivery systems market has been segmented into the following categories:
· By Product
o Prefilled Syringes
o Autoinjectors
o Infusion Pumps
o Metered Dose Inhalers (MDIs)
o Nebulizers
o Nasal Sprays
o Eyedroppers
o Intrauterine Devices (IUDs)
· By Route of Administration
o Transmucosal Drug Delivery
o Nasal Drug Delivery
o Oral Drug Delivery
o Topical Drug Delivery
o Implantable Drug Delivery
o Injectable Drug Delivery
o Ocular Drug Delivery
· By Application
o Cardiovascular Diseases
o Cancer
o Infectious Diseases
o Respiratory Diseases
o Central Nervous System Diseases
o Diabetes
o Others
o Ambulatory Surgical Centers
o Home Care Settings
o Diagnostic Centers
o Others
· By Region
o North America
o South America
o Europe
o Asia-Pacific
o Middle East and Africa
Key Players Landscape and Outlook
The global drug delivery systems market is currently witnessing a series of acquisitions. These strategic moves involve companies acquiring or merging with other entities to expand their product portfolios, enhance market presence, or access novel technologies. Acquisitions offer opportunities for companies to consolidate their positions, capitalize on synergies, and gain competitive advantages. They facilitate access to new markets, diversification of offerings, and acceleration of innovation by integrating complementary expertise. These transactions signify a dynamic phase within the drug delivery systems industry, aimed at reinforcing market foothold and fostering growth through strategic partnerships and expansions.
For instance, in July 2023, Novartis, a Swiss multinational pharmaceutical corporation, completed the acquisition of DTx Pharma, a startup specializing in RNA medicine delivery, for $500 million. DTx Pharma's Fatty Acid Ligand Conjugated Oligonucleotide (FALCON) platform enables the delivery of siRNA therapeutics outside the liver.
Key Players Operating in Global Drug Delivery Systems Market are:
· Sharps Technology Inc.
· Becton, Dickinson and Company
· Cardinal Health
· Novo Nordisk A/S
· Terumo Corporation
· Insulet Corporation
· Enable Injections, Inc.
· Bespak Europe Ltd.
· West Pharmaceutical Services, Inc.
· Novartis International AG
· Merck & Co., Inc.
· Sanofi S.A.
Markets and Data report answers the following questions:
· What is the current and future market size of the product/service in question globally or specific to different countries?
· How are the markets divided into different product/service segments and the market size and growth of each segment?
· What is the market potential of different product segments and their investment case?
· How are the markets predicted to develop in the future and what factors will drive or inhibit growth?
· What is the business environment and regulatory landscape specific to the product/service?
If you can't find what you're searching for or have any custom requirements for global drug delivery systems market, you may approach our team at info@marketsandata.com
Table of Contents
1. Research Methodology
2. Project Scope & Definitions
3. Executive Summary
4. Global Drug Delivery Systems Market Outlook, 2017-2031F
4.1. Market Size & Forecast
4.1.1.Value
4.1.2.Volume
4.2. By Product
4.2.2.Autoinjectors
4.2.3.Infusion Pumps
4.2.4.Metered Dose Inhalers (MDIs)
4.2.5.Nebulizers
4.2.6.Nasal Sprays
4.2.7.Eyedroppers
4.2.8.Intrauterine Devices (IUDs)
4.3. By Route of Administration
4.3.1.Pulmonary Drug Delivery
4.3.2.Transmucosal Drug Delivery
4.3.3.Nasal Drug Delivery
4.3.4.Oral Drug Delivery
4.3.5.Topical Drug Delivery
4.3.6.Implantable Drug Delivery
4.3.7.Injectable Drug Delivery
4.3.8.Ocular Drug Delivery
4.4. By Application
4.4.2.Cardiovascular Diseases
4.4.3.Cancer
4.4.4.Infectious Diseases
4.4.5.Respiratory Diseases
4.4.6.Central Nervous System Diseases
4.4.7.Diabetes
4.4.8.Others
4.5. By End-user
4.5.2.Ambulatory Surgical Centers
4.5.3.Home Care Settings
4.5.4.Diagnostic Centers
4.5.5.Others
4.6. By Region
4.6.1.North America
4.6.2.Europe
4.6.3.South America
4.6.4.Asia-Pacific
4.6.5.Middle East and Africa
4.7. By Company Market Share (%), 2023
5. Global Drug Delivery Systems Market Outlook, By Region, 2017-2031F
5.1. North America*
5.1.1. Market Size & Forecast
5.1.1.1. Value
5.1.1.2. Volume
5.1.2. By Product
5.1.2.2. Autoinjectors
5.1.2.3. Infusion Pumps
5.1.2.4. Metered Dose Inhalers (MDIs)
5.1.2.5. Nebulizers
5.1.2.6. Nasal Sprays
5.1.2.7. Eyedroppers
5.1.2.8. Intrauterine Devices (IUDs)
5.1.3. By Route of Administration
5.1.3.1. Pulmonary Drug Delivery
5.1.3.2. Transmucosal Drug Delivery
5.1.3.3. Nasal Drug Delivery
5.1.3.4. Oral Drug Delivery
5.1.3.5. Topical Drug Delivery
5.1.3.6. Implantable Drug Delivery
5.1.3.7. Injectable Drug Delivery
5.1.3.8. Ocular Drug Delivery
5.1.4. By Application
5.1.4.1. Autoimmune Diseases
5.1.4.2. Cardiovascular Diseases
5.1.4.3. Cancer
5.1.4.4. Infectious Diseases
5.1.4.5. Respiratory Diseases
5.1.4.6. Central Nervous System Diseases
5.1.4.7. Diabetes
5.1.4.8. Others
5.1.5. By End-user
5.1.5.2. Ambulatory Surgical Centers
5.1.5.3. Home Care Settings
5.1.5.4. Diagnostic Centers
5.1.5.5. Others
5.1.6. United States*
5.1.6.1. Market Size & Forecast
5.1.6.1.1. Value
5.1.6.1.2. Volume
5.1.6.2. By Product
5.1.6.2.1. Prefilled Syringes
5.1.6.2.2. Autoinjectors
5.1.6.2.3. Infusion Pumps
5.1.6.2.4. Metered Dose Inhalers (MDIs)
5.1.6.2.5. Nebulizers
5.1.6.2.6. Nasal Sprays
5.1.6.2.7. Eyedroppers
5.1.6.2.8. Intrauterine Devices (IUDs)
5.1.6.3. By Route of Administration
5.1.6.3.1. Pulmonary Drug Delivery
5.1.6.3.2. Transmucosal Drug Delivery
5.1.6.3.3. Nasal Drug Delivery
5.1.6.3.4. Oral Drug Delivery
5.1.6.3.5. Topical Drug Delivery
5.1.6.3.6. Implantable Drug Delivery
5.1.6.3.7. Injectable Drug Delivery
5.1.6.3.8. Ocular Drug Delivery
5.1.6.4. By Application
5.1.6.4.1. Autoimmune Diseases
5.1.6.4.2. Cardiovascular Diseases
5.1.6.4.3. Cancer
5.1.6.4.4. Infectious Diseases
5.1.6.4.5. Respiratory Diseases
5.1.6.4.6. Central Nervous System Diseases
5.1.6.4.7. Diabetes
5.1.6.4.8. Others
5.1.6.5. By End-user
5.1.6.5.1. Hospitals
5.1.6.5.2. Ambulatory Surgical Centers
5.1.6.5.3. Home Care Settings
5.1.6.5.4. Diagnostic Centers
5.1.6.5.5. Others
5.1.7. Canada
5.1.8. Mexico
*All segments will be provided for all regions and countries covered
5.2. Europe
5.2.1. Germany
5.2.2. France
5.2.3. Italy
5.2.4. United Kingdom
5.2.5. Russia
5.2.6. Netherlands
5.2.7. Spain
5.2.8. Turkey
5.2.9. Poland
5.3. South America
5.3.1. Brazil
5.3.2. Argentina
5.4. Asia-Pacific
5.4.1. India
5.4.2. China
5.4.3. Japan
5.4.4. Australia
5.4.5. Vietnam
5.4.6. South Korea
5.4.7. Indonesia
5.4.8. Philippines
5.5. Middle East & Africa
5.5.1. Saudi Arabia
5.5.2. UAE
5.5.3. South Africa
6. Market Mapping, 2023
6.1. By Product
6.2. By Route of Administration
6.3. By Application
6.4. By End-user
6.5. By Region
7. Macro Environment and Industry Structure
7.1. Supply Demand Analysis
7.2. Import Export Analysis
7.3. Value Chain Analysis
7.4. PESTEL Analysis
7.4.1. Political Factors
7.4.2. Economic System
7.4.3. Social Implications
7.4.4. Technological Advancements
7.4.5. Environmental Impacts
7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
7.5. Porter’s Five Forces Analysis
7.5.1. Supplier Power
7.5.2. Buyer Power
7.5.3. Substitution Threat
7.5.4. Threat from New Entrant
7.5.5. Competitive Rivalry
8. Market Dynamics
8.1. Growth Drivers
8.2. Growth Inhibitors (Challenges and Restraints)
9. Regulatory Framework and Innovation
9.1. Clinical Trials
9.2. Patent Landscape
9.3. Regulatory Approvals
9.4. Innovations/Emerging Technologies
10. Key Players Landscape
10.1. Competition Matrix of Top Five Market Leaders
10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
10.4. SWOT Analysis (For Five Market Players)
10.5. Patent Analysis (If Applicable)
11. Pricing Analysis
12. Case Studies
13. Key Players Outlook
13.1.1. Company Details
13.1.2. Key Management Personnel
13.1.3. Products & Services
13.1.4. Financials (As reported)
13.1.5. Key Market Focus & Geographical Presence
13.1.6. Recent Developments
13.2. Becton, Dickinson and Company
13.3. Cardinal Health
13.4. Novo Nordisk A/S
13.5. Terumo Corporation
13.6. Insulet Corporation
13.7. Enable Injections, Inc.
13.8. Bespak Europe Ltd.
13.9. West Pharmaceutical Services, Inc.
13.10. Novartis International AG
13.11. Merck & Co., Inc.
13.12. Sanofi S.A.
*Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work
14. Strategic Recommendations
15. About Us & Disclaimer
List of Figures
Figure 1. Global Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
Figure 2. Global Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
Figure 3. Global Drug Delivery Systems Market Share (%), By Product, 2017-2031F
Figure 4. Global Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
Figure 5. Global Drug Delivery Systems Market Share (%), By Application, 2017-2031F
Figure 6. Global Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
Figure 7. Global Drug Delivery Systems Market Share (%), By Region, 2017-2031F
Figure 8. North America Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
Figure 9. North America Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
Figure 10. North America Drug Delivery Systems Market Share (%), By Product, 2017-2031F
Figure 11. North America Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
Figure 12. North America Drug Delivery Systems Market Share (%), By Application, 2017-2031F
Figure 13. North America Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
Figure 14. North America Drug Delivery Systems Market Share (%), By Country, 2017-2031F
Figure 15. United States Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
Figure 16. United States Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
Figure 17. United States Drug Delivery Systems Market Share (%), By Product, 2017-2031F
Figure 18. United States Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
Figure 19. United States Drug Delivery Systems Market Share (%), By Application, 2017-2031F
Figure 20. United States Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
Figure 21. Canada Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
Figure 22. Canada Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
Figure 23. Canada Drug Delivery Systems Market Share (%), By Product, 2017-2031F
Figure 24. Canada Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
Figure 25. Canada Drug Delivery Systems Market Share (%), By Application, 2017-2031F
Figure 26. Canada Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
Figure 27. Mexico Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
Figure 28. Mexico Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
Figure 29. Mexico Drug Delivery Systems Market Share (%), By Product, 2017-2031F
Figure 30. Mexico Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
Figure 31. Mexico Drug Delivery Systems Market Share (%), By Application, 2017-2031F
Figure 32. Mexico Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
Figure 33. Europe Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
Figure 34. Europe Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
Figure 35. Europe Drug Delivery Systems Market Share (%), By Product, 2017-2031F
Figure 36. Europe Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
Figure 37. Europe Drug Delivery Systems Market Share (%), By Application, 2017-2031F
Figure 38. Europe Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
Figure 39. Europe Drug Delivery Systems Market Share (%), By Country, 2017-2031F
Figure 40. Germany Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
Figure 41. Germany Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
Figure 42. Germany Drug Delivery Systems Market Share (%), By Product, 2017-2031F
Figure 43. Germany Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
Figure 44. Germany Drug Delivery Systems Market Share (%), By Application, 2017-2031F
Figure 45. Germany Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
Figure 46. France Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
Figure 47. France Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
Figure 48. France Drug Delivery Systems Market Share (%), By Product, 2017-2031F
Figure 49. France Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
Figure 50. France Drug Delivery Systems Market Share (%), By Application, 2017-2031F
Figure 51. France Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
Figure 52. Italy Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
Figure 53. Italy Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
Figure 54. Italy Drug Delivery Systems Market Share (%), By Product, 2017-2031F
Figure 55. Italy Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
Figure 56. Italy Drug Delivery Systems Market Share (%), By Application, 2017-2031F
Figure 57. Italy Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
Figure 58. United Kingdom Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
Figure 59. United Kingdom Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
Figure 60. United Kingdom Drug Delivery Systems Market Share (%), By Product, 2017-2031F
Figure 61. United Kingdom Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
Figure 62. United Kingdom Drug Delivery Systems Market Share (%), By Application, 2017-2031F
Figure 63. United Kingdom Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
Figure 64. Russia Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
Figure 65. Russia Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
Figure 66. Russia Drug Delivery Systems Market Share (%), By Product, 2017-2031F
Figure 67. Russia Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
Figure 68. Russia Drug Delivery Systems Market Share (%), By Application, 2017-2031F
Figure 69. Russia Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
Figure 70. Netherlands Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
Figure 71. Netherlands Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
Figure 72. Netherlands Drug Delivery Systems Market Share (%), By Product, 2017-2031F
Figure 73. Netherlands Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
Figure 74. Netherlands Drug Delivery Systems Market Share (%), By Application, 2017-2031F
Figure 75. Netherlands Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
Figure 76. Spain Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
Figure 77. Spain Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
Figure 78. Spain Drug Delivery Systems Market Share (%), By Product, 2017-2031F
Figure 79. Spain Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
Figure 80. Spain Drug Delivery Systems Market Share (%), By Application, 2017-2031F
Figure 81. Spain Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
Figure 82. Turkey Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
Figure 83. Turkey Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
Figure 84. Turkey Drug Delivery Systems Market Share (%), By Product, 2017-2031F
Figure 85. Turkey Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
Figure 86. Turkey Drug Delivery Systems Market Share (%), By Application, 2017-2031F
Figure 87. Turkey Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
Figure 88. Poland Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
Figure 89. Poland Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
Figure 90. Poland Drug Delivery Systems Market Share (%), By Product, 2017-2031F
Figure 91. Poland Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
Figure 92. Poland Drug Delivery Systems Market Share (%), By Application, 2017-2031F
Figure 93. Poland Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
Figure 94. South America Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
Figure 95. South America Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
Figure 96. South America Drug Delivery Systems Market Share (%), By Product, 2017-2031F
Figure 97. South America Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
Figure 98. South America Drug Delivery Systems Market Share (%), By Application, 2017-2031F
Figure 99. South America Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
Figure 100. South America Drug Delivery Systems Market Share (%), By Country, 2017-2031F
Figure 101. Brazil Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
Figure 102. Brazil Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
Figure 103. Brazil Drug Delivery Systems Market Share (%), By Product, 2017-2031F
Figure 104. Brazil Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
Figure 105. Brazil Drug Delivery Systems Market Share (%), By Application, 2017-2031F
Figure 106. Brazil Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
Figure 107. Argentina Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
Figure 108. Argentina Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
Figure 109. Argentina Drug Delivery Systems Market Share (%), By Product, 2017-2031F
Figure 110. Argentina Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
Figure 111. Argentina Drug Delivery Systems Market Share (%), By Application, 2017-2031F
Figure 112. Argentina Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
Figure 113. Asia-Pacific Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
Figure 114. Asia-Pacific Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
Figure 115. Asia-Pacific Drug Delivery Systems Market Share (%), By Product, 2017-2031F
Figure 116. Asia-Pacific Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
Figure 117. Asia-Pacific Drug Delivery Systems Market Share (%), By Application, 2017-2031F
Figure 118. Asia-Pacific Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
Figure 119. Asia-Pacific Drug Delivery Systems Market Share (%), By Country, 2017-2031F
Figure 120. India Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
Figure 121. India Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
Figure 122. India Drug Delivery Systems Market Share (%), By Product, 2017-2031F
Figure 123. India Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
Figure 124. India Drug Delivery Systems Market Share (%), By Application, 2017-2031F
Figure 125. India Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
Figure 126. China Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
Figure 127. China Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
Figure 128. China Drug Delivery Systems Market Share (%), By Product, 2017-2031F
Figure 129. China Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
Figure 130. China Drug Delivery Systems Market Share (%), By Application, 2017-2031F
Figure 131. China Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
Figure 132. Japan Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
Figure 133. Japan Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
Figure 134. Japan Drug Delivery Systems Market Share (%), By Product, 2017-2031F
Figure 135. Japan Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
Figure 136. Japan Drug Delivery Systems Market Share (%), By Application, 2017-2031F
Figure 137. Japan Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
Figure 138. Australia Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
Figure 139. Australia Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
Figure 140. Australia Drug Delivery Systems Market Share (%), By Product, 2017-2031F
Figure 141. Australia Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
Figure 142. Australia Drug Delivery Systems Market Share (%), By Application, 2017-2031F
Figure 143. Australia Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
Figure 144. Vietnam Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
Figure 145. Vietnam Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
Figure 146. Vietnam Drug Delivery Systems Market Share (%), By Product, 2017-2031F
Figure 147. Vietnam Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
Figure 148. Vietnam Drug Delivery Systems Market Share (%), By Application, 2017-2031F
Figure 149. Vietnam Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
Figure 150. South Korea Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
Figure 151. South Korea Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
Figure 152. South Korea Drug Delivery Systems Market Share (%), By Product, 2017-2031F
Figure 153. South Korea Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
Figure 154. South Korea Drug Delivery Systems Market Share (%), By Application, 2017-2031F
Figure 155. South Korea Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
Figure 156. Indonesia Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
Figure 157. Indonesia Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
Figure 158. Indonesia Drug Delivery Systems Market Share (%), By Product, 2017-2031F
Figure 159. Indonesia Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
Figure 160. Indonesia Drug Delivery Systems Market Share (%), By Application, 2017-2031F
Figure 161. Indonesia Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
Figure 162. Philippines Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
Figure 163. Philippines Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
Figure 164. Philippines Drug Delivery Systems Market Share (%), By Product, 2017-2031F
Figure 165. Philippines Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
Figure 166. Philippines Drug Delivery Systems Market Share (%), By Application, 2017-2031F
Figure 167. Philippines Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
Figure 168. Middle East & Africa Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
Figure 169. Middle East & Africa Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
Figure 170. Middle East & Africa Drug Delivery Systems Market Share (%), By Product, 2017-2031F
Figure 171. Middle East & Africa Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
Figure 172. Middle East & Africa Drug Delivery Systems Market Share (%), By Application, 2017-2031F
Figure 173. Middle East & Africa Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
Figure 174. Middle East & Africa Drug Delivery Systems Market Share (%), By Country, 2017-2031F
Figure 175. Saudi Arabia Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
Figure 176. Saudi Arabia Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
Figure 177. Saudi Arabia Drug Delivery Systems Market Share (%), By Product, 2017-2031F
Figure 178. Saudi Arabia Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
Figure 179. Saudi Arabia Drug Delivery Systems Market Share (%), By Application, 2017-2031F
Figure 180. Saudi Arabia Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
Figure 181. UAE Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
Figure 182. UAE Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
Figure 183. UAE Drug Delivery Systems Market Share (%), By Product, 2017-2031F
Figure 184. UAE Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
Figure 185. UAE Drug Delivery Systems Market Share (%), By Application, 2017-2031F
Figure 186. UAE Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
Figure 187. South Africa Drug Delivery Systems Market, By Value, In USD Billion, 2017-2031F
Figure 188. South Africa Drug Delivery Systems Market, By Volume, In Million Units, 2017-2031F
Figure 189. South Africa Drug Delivery Systems Market Share (%), By Product, 2017-2031F
Figure 190. South Africa Drug Delivery Systems Market Share (%), By Route of Administration, 2017-2031F
Figure 191. South Africa Drug Delivery Systems Market Share (%), By Application, 2017-2031F
Figure 192. South Africa Drug Delivery Systems Market Share (%), By End-user, 2017-2031F
Figure 193. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 194. By Route of Administration Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 195. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 196. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023
List of Tables
Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects
Frequently Asked Questions
Who are the key players operating in the global drug delivery systems market?
What are the regions covered in the final report for global drug delivery systems market?
What are the major factors influencing the growth of the global drug delivery systems market?
What is the market size and growth rate of the global drug delivery systems market?
See Related Reports
Global Bone Densitometers Market Assessment, Opportunities and Forecast, 2017-2031F
There is an increased demand for dual-energy x-ray absorptiometry (DXA) in the global bone densitometers market. Also, increasing prevalence of osteoporosis, growing geriatric population, technological advancements, and collaborative research and new....Read More
Published on
May 2024
4,500
Global Medical Terminology Software Market Assessment, Opportunities and Forecast, 2017-2031F
Global medical terminology software market is expected to witness significant growth over the forecast period owing to an increase in measures for reducing clinical errors and rising investments towards the development of technologically advanced sol....Read More
Published on
May 2024
4,500
Global Legionella Testing Market Assessment, Opportunities and Forecast, 2017-2031F
Global legionella testing market will witness significant growth owing to the rapid expansion of the healthcare sector, increasing awareness about the importance of regular legionella testing, and rising prevalence of legionella related illnesses.....Read More
Published on
May 2024
4,500
Global Endoluminal Suturing Devices Market Assessment, Opportunities and Forecast, 2017-2031F
Global endoluminal suturing devices market is expected to witness significant growth over the forecast period owing to rise in the number of cases of gastrointestinal cancer and increasing preference for non-invasive procedures.....Read More
Published on
May 2024
4,500
Purchase Options
USD ($)
i
3,000
i
4,500
i
5,700
i
8,200
Tired of Searching?
Looking for Customization?
Some other doubt?
Need insights from a cohort?
REACH US
